High-sensitivity troponin T is detectable in most patients with clinically stable heart failure

British Journal of Cardiology

Volumn 21, Issue 1, 2014, Pages 33-36

  Lyons, Kristopher S ^a   McKeeman, Gareth ^b   McVeigh, Gary E ^a   Harbinson, Mark T ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Acute coronary syndrome; Heart failure; Troponin

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; TROPONIN T; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VALVE REGURGITATION; HEART VALVE STENOSIS; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER;

EID: 84899668215     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: 10.5837/bjc.2014.005     Document Type: Article

References (12)

1. Hamm CW, Bassand J-P, Agewall S et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054. http://dx.doi.org/ 10.1093/eurheartj/ehr236
2. Januzzi J, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart failure section. Eur Heart J 2012; 33:2265-71. http://dx.doi.org/10.1093/eurheartj/ehs191
3. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in heart failure: prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010;56:1071-8. http://dx.doi.org/10.1016/j. jacc.2010.06.016
4. Wang TJ. Significance of circulating troponins in heart failure. Circulation 2007;116:1217-20. http://dx.doi.org/10.1161/CIRCULATIONAHA.107. 721845 (Pubitemid 47517530)
5. Sato Y, Yamada T, Taniguchi R et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103:369-74. http://dx.doi.org/10.1161/01.CIR.103.3.369 (Pubitemid 32105975)
6. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833-8. http://dx.doi.org/10.1161/01.CIR.0000084543.79097.34 (Pubitemid 37022125)
7. Nagarajan V, Hernandez A, Tang WHW. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart 2012;98:1778-86. http://dx.doi.org/10.1136/heartjnl-2012-301779
8. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61. http://dx.doi.org/10.1373/clinchem.2009.132654
9. Tentzeris I, Jarai R, Farhan S et al. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail 2011;13:726-33. http://dx.doi.org/10.1093/ eurjhf/hfr049
10. Kawahara CH, Tsutamoto T, Nishiyama K et al. Prognostic role of highsensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J 2011;75:656-61. http://dx.doi.org/10.1253/circj.CJ-10- 0837
11. Latini R, Masson S, Anand IS et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.655076 (Pubitemid 47517535)
12. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67. http://dx.doi.org/10.1093/ eurheartj/ehs184